Together with the aforementioned findings [50, 53], these studies suggest that Wnt5B-mediated noncanonical Wnt signaling may exert a detrimental effect in COPD patients to promote small airway remodeling, which may represent a therapeutic target for COPD treatment [53]. The gene discussed is WNT5B; the disease is chronic obstructive pulmonary disease.